146 related articles for article (PubMed ID: 38241617)
1. Anisometropia and Amblyopia Outcomes in Early Versus Late Resolution of Congenital Nasolacrimal Duct Obstruction in Older Infants.
Sims DT; Gillette TB; Lam JG; Liu D; Lee C; Ding L; Tarczy-Hornoch K; Cabrera MT
Ophthalmic Plast Reconstr Surg; 2024 Jan-Feb 01; 40(1):39-42. PubMed ID: 38241617
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of amblyogenic factors in children with persistent congenital nasolacrimal duct obstruction.
Eshraghi B; Akbari MR; Fard MA; Shahsanaei A; Assari R; Mirmohammadsadeghi A
Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1847-52. PubMed ID: 24777709
[TBL] [Abstract][Full Text] [Related]
3. Neonatal dacryostenosis as a risk factor for anisometropia.
Piotrowski JT; Diehl NN; Mohney BG
Arch Ophthalmol; 2010 Sep; 128(9):1166-9. PubMed ID: 20837801
[TBL] [Abstract][Full Text] [Related]
4. Anisometropia and refractive status in children with congenital nasolacrimal duct obstruction-a prospective observational study.
Hareendran H; Allapitchai F; Ravindran M; Shukul K; Rengappa R
J AAPOS; 2022 Apr; 26(2):76.e1-76.e4. PubMed ID: 35314316
[TBL] [Abstract][Full Text] [Related]
5. Anisometropia and amblyopia in nasolacrimal duct obstruction.
Kipp MA; Kipp MA; Struthers W
J AAPOS; 2013 Jun; 17(3):235-8. PubMed ID: 23602456
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Anisometropia and Refractive Status in Children With Unilateral and Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Mansoor H; Asif M; Wakeel U; Saleem AA
J Pediatr Ophthalmol Strabismus; 2016 May; 53(3):168-72. PubMed ID: 27224951
[TBL] [Abstract][Full Text] [Related]
7. Anisometropic amblyopia and nasolacrimal duct obstruction.
Simon JW; Ngo Y; Ahn E; Khachikian S
J Pediatr Ophthalmol Strabismus; 2009; 46(3):182-3. PubMed ID: 19496504
[TBL] [Abstract][Full Text] [Related]
8. Anisometropia and Refractive Status in Children with Bilateral Congenital Nasolacrimal Duct Obstruction.
Siddiqui SN; Hannan A; Mansoor H; Asif M; Wakeel U
J Coll Physicians Surg Pak; 2018 Mar; 28(3):210-213. PubMed ID: 29544578
[TBL] [Abstract][Full Text] [Related]
9. Amblyopia Risk Factors in Newborns With Congenital Nasolacrimal Duct Obstruction.
Vagge A; Tulumello C; Pellegrini M; Di Maita M; Iester M; Traverso CE
J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):39-43. PubMed ID: 31972039
[TBL] [Abstract][Full Text] [Related]
10. Nasolacrimal duct obstruction: Does it really increase the risk of amblyopia in children?
Ramkumar VA; Agarkar S; Mukherjee B
Indian J Ophthalmol; 2016 Jul; 64(7):496-9. PubMed ID: 27609160
[TBL] [Abstract][Full Text] [Related]
11. Timing of congenital dacryostenosis resolution and the development of anisometropia.
Pyi Son MK; Hodge DO; Mohney BG
Br J Ophthalmol; 2014 Aug; 98(8):1112-5. PubMed ID: 24682178
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of amblyopia in children undergoing nasolacrimal duct irrigation and probing.
Ozgur OR; Sayman IB; Oral Y; Akmaz B
Indian J Ophthalmol; 2013 Dec; 61(12):698-700. PubMed ID: 24413822
[TBL] [Abstract][Full Text] [Related]
13. Unilateral Congenital Nasolacrimal Duct Obstruction, Is It An Amblyogenic Factor?
AlHammad F; Al Tamimi E; Yassin S; AlBadri K; AlJarudi S; AlShawaf M; Khandekar R
Middle East Afr J Ophthalmol; 2018; 25(3-4):156-160. PubMed ID: 30765954
[TBL] [Abstract][Full Text] [Related]
14. Amblyopia risk factors in infants with congenital nasolacrimal duct obstruction.
Kim JW; Lee H; Chang M; Park M; Lee TS; Baek S
J Craniofac Surg; 2013 Jul; 24(4):1123-5. PubMed ID: 23851753
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous Resolution and Timing of Intervention in Congenital Nasolacrimal Duct Obstruction.
Sathiamoorthi S; Frank RD; Mohney BG
JAMA Ophthalmol; 2018 Nov; 136(11):1281-1286. PubMed ID: 30178001
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Lacrimal Sac Massage in Management of Congenital Nasolacrimal Duct Obstruction in Infants: An Observational Study of 853 Cases from a Single Institute of Eastern Asia.
Nanda D; Sarkar M
Middle East Afr J Ophthalmol; 2022; 29(4):216-219. PubMed ID: 38162564
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of amblyopia risk factors in congenital nasolacrimal duct obstruction.
Matta NS; Singman EL; Silbert DI
J AAPOS; 2010 Oct; 14(5):386-8. PubMed ID: 21035062
[TBL] [Abstract][Full Text] [Related]
18. Congenital nasolacrimal duct obstruction continues trend for spontaneous resolution beyond first year of life.
Nakayama T; Watanabe A; Rajak S; Yamanaka Y; Sotozono C
Br J Ophthalmol; 2020 Aug; 104(8):1161-1163. PubMed ID: 31676597
[TBL] [Abstract][Full Text] [Related]
19. Probing for congenital nasolacrimal duct obstruction.
Petris C; Liu D
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of amblyopia risk factors in preverbal children with nasolacrimal duct obstruction.
Matta NS; Silbert DI
J AAPOS; 2011 Aug; 15(4):350-2. PubMed ID: 21907117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
